AI Article Synopsis

  • Transgender women in the U.S. experience higher rates of HIV and substance use, prompting a need for research on the relationship between the two.
  • A study involving 214 transgender women in NYC investigated day-to-day associations between heavy drinking, marijuana use, and nonprescription stimulant use with sexual activity and HIV transmission risk behavior (TRB).
  • Results showed links between substance use and increased sexual activity, particularly heavy drinking and stimulant use, while only marijuana use was significantly associated with higher TRB on days of sexual activity, underlining the need to address substance use in sexual health strategies for transgender women.

Article Abstract

Transgender women in the United States face elevated rates of HIV and of substance use. Studies measuring overall or aggregate levels of substance use have linked use to increased HIV transmission risk behavior (TRB). Although intensive longitudinal studies in other populations have found day-level links between substance use and TRB, no study has yet explored such links among transgender women. This study aimed to fill this gap in the literature. Utilizing survey and 60-day timeline follow-back interview data from a sample of 214 transgender women in New York City, we tested whether day-level heavy drinking, marijuana use, and/or nonprescription stimulant use were associated with odds of engaging in any sex (vs. no sexual activity) or engaging in TRB (vs. sex without TRB), adjusting for overall levels of use. Multilevel models showed that each of the three substance types was associated with greater odds of engaging in sex on a given day-and more strongly so for heavy drinking among those with higher rates of heavy drinking, and for stimulant use among those with lower rates of stimulant use. Only marijuana use was associated with greater odds of TRB on a given day, but only among those with higher rates of use. These findings substantiate day-level links between substance use and engaging in sexual activity among transgender women, and importantly, between marijuana use and greater likelihood of TRB on a day when sexual activity occurs. This highlights the importance of addressing substance use for sexual health among transgender women especially focusing on marijuana use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308277PMC
http://dx.doi.org/10.1089/trgh.2018.0032DOI Listing

Publication Analysis

Top Keywords

transgender women
24
heavy drinking
12
sexual activity
12
risk behavior
8
day-level links
8
links substance
8
odds engaging
8
engaging sex
8
associated greater
8
greater odds
8

Similar Publications

Article Synopsis
  • The National Surveys of Sexual Attitudes and Lifestyles (Natsal) aim to estimate the prevalence of sexually transmitted infections (STIs) in Britain through biosampling, evaluating methods for acceptability and response rates.
  • Two pilot studies were conducted with participants aged 16-59, who provided urine or vaginal swab samples either during face-to-face interviews or remotely, with feedback collected to assess the processes.
  • Out of 261 participants, 62% consented to biosampling, with a higher sample return from face-to-face interviews, indicating general acceptability of the biosampling methods used for STI testing in the national survey.
View Article and Find Full Text PDF

Context: Guidelines for use of injectable estradiol esters (valerate [EV] and cypionate [EC]) among transgender and gender diverse (TGD) individuals designated male at birth vary considerably, with many providers noting supraphysiologic serum estradiol concentrations based on current dosing recommendations.

Objectives: 1. Determine dose of injectable estradiol (subcutaneous [SC] and intramuscular [IM]) needed to reach guideline-recommended estradiol concentrations for TGD adults using EC/EV.

View Article and Find Full Text PDF

Background: Little is known about the efficacy of preexposure prophylaxis (PrEP) or what biologic factors may influence HIV transmission in transgender men (TGM). In this study, we sought to explore the effect of testosterone on the vaginal microbiome, cervicovaginal fluid (CVF) tenofovir concentrations, and levels of CVF inflammatory markers in TGM on PrEP.

Methods: Cervicovaginal fluid was collected from 13 TGM (7 using testosterone) and 32 cisgender women (CGW) on PrEP.

View Article and Find Full Text PDF

Introduction: Cardiovascular diseases (CVDs) present differently in women and men, influenced by host-microbiome interactions. The roles of sex hormones in CVD outcomes and gut microbiome in modifying these effects are poorly understood. The XCVD study examines gut microbiome mediation of sex hormone effects on CVD risk markers by observing transgender participants undergoing gender-affirming hormone therapy (GAHT), with findings expected to extrapolate to cisgender populations.

View Article and Find Full Text PDF

Background: Trans girls may initiate early puberty blockers once puberty has started in order to prevent the development of masculine secondary sexual characteristics. Depending on how early the puberty blockers are administered, voice may have reached a certain degree of development and have acquired typically male acoustic and phonetic parameters, which can cause discomfort and affect the adolescent's quality of life.

Purpose: The aim of the present study was to (1) determine if there are differences in discomfort with the self-perceiver voice according to the moment of puberty block (PB), and (2) find a relation between vocal discomfort and variables such a voice phonetic/acoustic characteristics and self-perception of voice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!